Abstract The aim of this study was to evaluate the clinical, anti-inflammatory, and osteoimmunological benefits of the single (PT) and repeated laser phototherapy (rPT) as an adjunctive treatment of inflamed periodontal tissue. Twenty-seven patients with chronic periodontitis were randomly divided into three groups of nine patients each in order to undergo scaling and root planing (SRP), SRP followed by one session of adjunctive PT (Day 1; SRP+PT), or SRP followed by adjunctive repeated PT five times in 2 weeks (Days 1, 2, 4, 7, and 11; SRP+rPT). For phototherapy session, a diode laser (λ0670 nm, 200 mW, 60 s/tooth) was applied into the sulcus. Clinical parameters, including full-mouth plaque score, full-mouth bleeding score, probing pocket depth, and clinical attachment level were recorded. Samples of gingival crevicular fluid (GCF) were taken at baseline, 4, and 8 weeks after treatment. Interleukin 1beta (IL-1β), tumor necrosis factor alpha (TNF-α), receptor activator of nuclear factor κΒ ligand (RANKL), and osteoprotegerin (OPG) levels in the collected GCF were measured. PT used in a single or repeated doses, does not produce a significant reduction in the clinical parameters essayed (p>0.05). Levels of IL-1β in GCF were significantly reduced in SRP+PT and SRP+rPT groups compared with the SRP group (p<0.05). However, the SRP+rPT group showed a significant reduction of pro-inflammatory cytokine TNF-α and RANKL/ OPG ratio at 4 weeks post-treatment compared with the SRP + PT and SRP groups (p < 0.05). SRP + PT group also showed a significant reduction in TNF-α and RANKL/OPG ratio at 8 weeks post-treatment compared with the SRP group (p<0.05). PT exerts a biostimulative effect on the periodontal tissue. Multiple sessions of PT showed a faster and greater tendency to reduce proinflammatory mediators and RANKL/OPG ratio.
Introduction
Periodontitis is an inflammatory disease characterized by periodontal pocket formation and alveolar bone resorption that may result in tooth loss. Immune responses against periodontal pathogens can greatly affect the course of periodontal diseases but the mechanisms by which local immune responses against periodontopathic bacteria result in alveolar bone resorption remain to be established in further studies.
In periodontal lesions, lymphocytes, macrophages, and neutrophils infiltrate the gingival connective tissue and interact with stromal cells. It should be noted that the interaction between stromal cells (osteoblasts, periodontal ligament fibroblasts, and gingival fibroblasts) and inflammatory mediators, including interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and prostaglandin PGE 2 can induce bone resorption by indirectly stimulating osteoblasts to produce receptor activator of nuclear factor κΒ ligand (RANKL). T lymphocytes can also promote osteoclast differentiation by direct production of RANKL [1] . Alveolar bone resorption might be directly or indirectly induced by the inflammatory infiltrate in periodontal lesions [1] .
Recent advances in osteoimmunology have led us to examine the role of RANKL and osteoprotegerin (OPG) in the pathogenesis of periodontitis. Crotti et al. [2] compared both RANKL and OPG expression in the granulomatous tissue adjacent to areas of alveolar bone loss as a result of periodontitis, by means of immunohistochemistry. Significantly higher levels of RANKL protein were expressed in the periodontal tissue, whereas OPG protein levels were significantly lower. While RANKL protein was associated with lymphocytes and macrophages, OPG protein was associated with endothelial cells. To date, all decisions concerning treatment methods are based on the clinical morphological diagnosis. If the molecular mechanism of alveolar bone resorption is elucidated in detail, prognosis of the periodontal lesion will be more accurately diagnosed, and then appropriate treatment modalities could be proposed.
On the other hand, lasers have been extensively used in the treatment of periodontal disease. However, the variety of biological effects of laser radiation on oral tissue is still not fully understood. Among the many physiological effects, it should be noted that the biostimulatory effects, which laser radiation produces in tissue cells during laser therapy might, promote faster tissue repair and wound healing, which may not occur during conventional mechanical therapy. It has been suggested that low-level laser energy is responsible for these biomodulatory effects [3] . The effects of low-level laser energy on cells are related to photochemical reactions within the cells, rather than through a thermal effect. Yet, the precise mechanism behind this is still unclear. Nevertheless, biostimulatory effects of laser irradiation, such as higher cell proliferation and wound healing [4] may have interesting applications in current therapy. Recently, a significant increase in ATP production was reported in living cells after laser radiation at 904, 632.8, and 830 nm [5, 6] .
To date, only a few clinical studies have been published on the effects of adjunctive low-level laser therapy in periodontal therapy [7] [8] [9] . Thus, at present, the superiority of this novel treatment approach compared with conventional treatment has not been clearly established. Therefore, further clinical studies are needed to demonstrate the real beneficial effects of low-level laser therapy in periodontal treatment. The aim of the present short-term clinical study was to compare the clinical, anti-inflammatory, and osteoimmunological outcomes of conventional root debridement with or without the use of adjunctive single or repeated PT in patients with chronic periodontitis.
Materials and methods

Patients
A sample of nine subjects per group (27 in total, 12 men and 15 women), with moderate-advanced chronic periodontitis was recruited from the Department of Stomatology III of the University Complutense of Madrid, and consecutively enrolled between March 2010 and January 2011. The mean age was 50.44±15.91 for the scaling and root planing (SRP) group, 52.89±11.98 for the SRP followed by simple phototherapy (PT) group (SRP+PT group) and 50.44±10.51 for the SRP followed by repeated PT group (SRP+rPT group). The inclusion criteria were as follows: having four or more teeth per quadrant without crowns, bridges or a removable denture support, or amalgams type II or IV, as well as a probing pocket depth of 4 to 6 mm. On the other hand, patient exclusion criteria were: being a smoker or former smoker, having had a previous history of periodontal treatment within the last year, having undergone antibiotic therapy within the previous 3 months, the use of antiseptic mouthrinses, corticosteroid or immunosuppressant medication, or any systemic condition that could affect the periodontal condition and/or the treatment protocol.
For ethical requirements, the procedure was explained and consent forms were signed by each patient. The study was conducted in full accordance with the declared ethical principles (World Medical Association Declaration of Helsinki, version VI, 2002) and was approved by the Ethics Committee of the Hospital Clínico San Carlos in Madrid, Spain.
Study design
Patients were assigned to receive either SRP, SRP+PT or SRP+rPT treatment based on a randomization list. The randomization protocol was carried out as an administrative task by staff who was not involved in patients' treatment.
Initially, all participants received basic periodontal treatment including scaling, root planing and oral hygiene instructions. Baseline measurements of the fullmouth plaque score (FMPS), full-mouth bleeding score (FMBS), probing pocket depth (PPD), and clinical attachment level (CAL) were recorded before SRP. Gingival crevicular fluid (GCF) samples were used to determine the levels of IL-1β, TNF-α, RANKL, and OPG in GCF. These samples were taken just before SRP. Four and eight weeks after treatment, the clinical examination and GCF sampling were carried out in the same way as at baseline for the three groups (SRP, SRP+PT, and SRP+rPT).
Oral hygiene program
Before treatment, all patients were instructed on the Bass brushing technique and in the ability to distinguish the presence or absence of bacterial plaque on tooth surfaces. Every subject was also instructed on the use of dental floss or interproximal brushes depending on their needs. Patient motivation is needed to achieve a proper plaque control. Patients did not use mouthrinses during the course of the study, to avoid alterations of the results.
Treatments
All 27 patients received basic periodontal treatment, which involved the removal of supragingival and subgingival plaque. Work schedule with the times of actuation is shown in Fig. 1 .
Removal of supragingival plaque was initially performed with ultrasonic instruments (sonic SONYflex 2003 Kavo) and a universal accessory tip, followed by an abrasive paste (Dentsply), which was applied using a natural bristle brush (diameter 8 mm for counter-angle; Stoddard). Mechanical subgingival instrumentation was performed by using Gracey curettes (HU-Friedy Co., Chicago, IL, USA). The instrumentation was finished when the operator judged the debridement to be adequately performed. SRP procedure was performed within 24 h in two sessions.
Phototherapy For the SRP+PT group, adjunctive phototherapy was performed 1 day after the SRP procedure (Day 1) using a 670-nm diode laser device (Periowave™, Ondine Biopharma) with a maximum power of 200 mW. A flexible optical fiber cable attached to a custom-designed autoclavable stainless steel handpiece was used. The handpiece accommodated a disposable light-diffusing tip that was configured similar to a periodontal probe to allow access to the periodontal pocket. All treatments were performed at a continuous power setting of 200 mW (verified before each treatment by using a power detector XLP12 by Gentec in combination with a Gentec-SOLO 2 console). The laser diffusing tip was partially inserted into the pocket, penetrating no deeper into the pocket than the probing depth, and was gently moved all along the sulcus (Fig. 2) . The laser radiation was applied for no longer than 60 s/tooth (30 s for the bucal surface and another 30 s for the lingual/ palatal surface and its interproximal sites too). The laser tip was discarded after each laser session. For the SRP+rPT group, adjunctive PT was repeated five times in 2 weeks (Days 1, 2, 4, 7, and 11) following the same methodology as SRP+PT group. Since the wavelength of 670 nm is not absorbed by plaque, a repeated use of this laser radiation does not lead to a higher plaque removal. During laser application, protective eyewear was worn by the patient, operator, and assistants.
Root surface instrumentation was performed by an investigator who was well trained in SRP. All groups were treated 
Clinical measurements
Before treatment, and 4 and 8 weeks after treatment, clinical parameters were measured by a calibrated periodontist who was not involved in providing treatment during the course of the study. This examiner underwent calibration training at the beginning of the study. Percentage agreement with another experienced examiner within 1 mm was >96 %. For probing measurements, a manual periodontal probe (UNC 15, Hu-Friedy Co., Chicago, IL, USA) was used.
The variables were recorded as follows:
FMPS was recorded as the percentage of tooth surfaces with the presence of plaque detected with the use of a periodontal probe, modified from O'Leary et al. FMBS was assessed simultaneously with the pocket measurements, based on the presence or absence of bleeding up to 30 s after probing was recorded. PPD was measured to the nearest millimeter from the gingival margin to the base of the clinical pocket. CAL was calculated as distance in millimeters from cement-enamel junction to the bottom of the pocket.
Six sites were examined for each tooth: mesiobuccal, buccal, distobuccal, distolingual, lingual, and mesiolingual.
Samples
Samples were taken from every patient, before treatment and 4 and 8 weeks after treatment (SRP alone, SRP+ PT, or SRP+rPT). In each of these three visits, four GCF samples were taken from those sides with the highest PPD (recording the same for each patient), excluding the last molars to avoid contamination with saliva. During the sampling, an average of two samples per patient were discarded because of contamination by blood. GCF was collected with prefabricated paper strips (Periopaper, Oraflow Inc., Plainview, NY, USA), which were inserted into the pockets until resistance was felt and left in place for 30 s. The volume of GCF was measured with a calibrated Periotron 8000 (curve of calibration using human serum as a calibrant was fitted with 4 th -order polynomial regression) [10] . The periopapers were then placed in sterile Eppendorfs with a filter and frozen at −80°C until laboratory analyses were achieved.
Laboratory analyses
IL-1β, TNF-α, RANKL, and OPG determination
Diluted GCF samples were analyzed for mediators using enzyme-linked immunosorbent assay (ELISA). The levels of IL-1β and TNF-α in GCF were determined (in duplicate) with the BLK-223 (human TNF-α ELISA kit) and BLK-224 (human IL-1β ELISA kit), respectively, both by Biolink (Biolink 2000, Barcelona, Spain), according to the manufacturer's instructions. The levels of RANKL and OPG in GCF were determined (in duplicate) with the K 1016-96 TestRANKL total-EIA (RANKL ELISA kit) and KB 1011-96 Tesosteoprogeterina (OPG ELISA kit), respectively, both of Immundiagnostik (Immundiagnostik, Bensheim, Germany), according to the manufacturer`s instructions. Results were calculated using the standard curves created for each assay. Cytokine concentrations were corrected for GCF volume and defined as picograms per microliter. The detection limit was determined to be 0.3 pg/mL for IL-1β, 3.83 pg/mL for TNF-α, 0.4 pmol/L for RANKL, and 0.14 pmol/L for OPG.
Statistical analysis
A software package SPSS 17.0 (SPSS, INC. Chicago, IL, USA) was used for statistical analysis. Descriptive statistical parameters (mean and standard deviation) were calculated. Differences in the treatment progress (between baseline, 4 and 8 weeks post-therapy) were analyzed between SRP, SRP + PT, and SRP + rPT groups. Comparisons within groups were made using a non-parametric Wilcoxon test. Comparisons between the three groups were made by using ANOVA analysis of variance complemented by post-hoc analysis. Values of p<0.05 were accepted as statistically significant. Fig. 2 Laser light was delivered by means of a light diffusing tip that was inserted to the periodontal pocket, and it was slowly moved around the pocket during the illumination cycle
Results
Results showed a remission of chronic periodontal disease in the three treatment groups. No adverse effects, such as burning sensation or pain, related to the laser irradiation were reported. In addition, there were no complications during the study period as abscesses or infections, so the three types of treatment were well tolerated.
The evolution of the assessed clinical indexes is summarized in Fig. 3 , which shows the mean FMPS, FMBS, and PPD values at baseline and at 4 and 8 weeks after treatment. Statistically significant intragroup differences were found for FMPS, FMBS, and PPD in the three groups (SRP, SRP+PT, and SRP+rPT) when comparing data at baseline with postoperative data at 4 and 8 weeks (p<0.05). The most noticeable reduction took place 4 weeks after therapy. The evolution of CAL values is shown in Table 1 ; these results showed the same tendency as the other clinical parameters above evaluated.
There were no statistically significant differences between the control group (SRP) and both groups of phototherapy (SRP+PT and SRP+rPT) as for the evolution of the clinical parameters studied from the initial state and the first and second reevaluations (p>0.05) ( Fig. 3; Table 1 ). Therefore, the analysis of the clinical parameters evaluated shows an improvement of the periodontal condition in the three groups studied, much more relevant at 4 weeks post-therapy. Phototherapy with 670-nm diode laser does not imply additional benefit in these clinical parameters compared with SRP alone in the treatment of chronic periodontitis.
The levels of IL-1β and TNF-α in GCF at baseline and postoperatively are shown in Fig. 4 . Levels of IL-1β increased progressively in the SRP group finding higher levels at 4 and 8 weeks post-therapy, with statistically significant differences in both reevaluations compared with baseline (p<0.05). In the SRP+PT group, IL-1β levels were slightly increased at 4 weeks post-therapy compared with baseline, to fall again at 8 weeks post-therapy, without being detected intragroup statistically significant differences in any of the two reeevaluations respect to baseline. However, in the SRP+rPT group, levels of IL-1β in the GCF were reduced both at 4 and 8 weeks post-treatment, being this reduction at the second reevaluation compared with baseline statistically significant (p<0.05). In addition, there were statistically significant differences between SRP and both groups of phototherapy as for the evolution of IL-1β levels in GCF, from the initial state and the first and second re-evaluations (p<0.05). Thus, Phototherapy constitutes a useful and effective tool/complement for the reduction of this mediator.
In the SRP group, levels of TNF-α increased both at 4 and 8 weeks post-therapy, being this last value different from a statistical point of view compared with baseline (p<0.05) (Fig 4b) . In the SRP+PT group, levels of TNF-α in GCF were increased at 4 weeks to back down at 8 weeks postoperative, although no statistically significant differences between first and second reevaluation and baseline state were observed. In the SRP+rPT group, levels of TNF-α in GCF underwent a marked decrease; statistically significant differences were found concerning the levels of TNF-α in the initial state and those obtained at 8 weeks post-therapy (p<0.05).
Statistically significant intergroup differences appeared in the SRP+rPT group against SRP and SRP+PT groups as for the evolution of the levels of TNF-α in GCF after 4 weeks after treatment (p<0.05). In addition, statistically significant differences were also found between the SRP+ rPT group and the SRP+PT group, and this is in turn, different from the SRP group as for the evolution of TNF-α levels after 8 weeks-postoperatively (p<0.05). Phototherapy applied in repeated doses during the first 2 weeks of treatment is a useful and effective complement in reducing this particular mediator.
Regarding the RANKL/OPG ratio, it was observed that, in the SRP group, this ratio increases slightly but steadily, both at 4 and at 8 weeks post-therapy, finding statistically significant differences between the initial state and the last reevaluation (p<0.05) (Fig. 5) . The group for SRP+PT initially showed rising values, reversing that behavior between 4 and 8 weeks post-treatment, although there were no statistically significant differences between these values and baseline. Meanwhile, in the SRP+rPT, we found that the RANKL/OPG ratio suffered a steady decline, being more pronounced at 4 weeks, and lighter at 8 weeks post-therapy. In this case, there are intragroup statistically significant differences in both the first and the second revaluation if it is compared with the initial state (p<0.05).
Statistically significant intergroup differences were detected in the SRP+rPT against SRP and SRP+PT in the evolution of the ratio RANKL/OPG in the GCF from the initial state and the first reevaluation (p<0.05). In addition, statistically significant differences were also found for the SRP+rPT group compared with SRP+PT group, and this is in turn different from the SRP group as for the evolution of RANKL/OPG ratio after 8 weeks-postoperatively (p<0.05). This analysis confirms that repeated phototherapy during the early stage of the treatment is essential in reducing this ratio and therefore more effective in the treatment of chronic periodontal disease, at the same time that the simple effect of a single dose of phototherapy shows an interesting medium-term action compared with conventional treatment.
Discussion
The non-surgical periodontal treatment is considered effective to remove periodontal microorganisms in order to control the progression of the disease. The subgingival SRP is the most important one, and its clinical efficacy has been demonstrated in numerous clinical studies [11, 12] , especially for periodontal pockets with a probing depth lower than 6 mm. However, with increasing pocket depth, plaque, and inflammation's control is complicated, and there have been recommended alternative methods as surgical procedures (flap surgery) or laser treatment, allowing better access of the root surface. The variety of biological effects which laser radiation may produce in the oral tissues is not completely understood yet. It is important to recognize beneficial biostimulant effects of laser radiation in cells of the oral tissues during laser therapy, such as the contribution to a faster healing during the reparation process of the periodontium, which may not take place during the conventional mechanical therapy. These biostimulant effects have been associated with the use of low level laser radiation [3] . Diode lasers: gallium arsenide and aluminum (GaAlAs), indium-gallium phosphate-aluminum (InGaAlP), and gallium arsenide (GaAs), along with helium-neon (He-Ne) laser, allow this photobiomodulatory effect [13, 14] . According to the first law of photochemistry, the biological effect observed after the application of laser radiation of low energetic level, can only be a result of the presence of a photoacceptor molecule, able to absorb the photonic energy emitted [14] . Additionally, there are no photothermal nor photoacoustic mechanisms associated to this effect, so no heating is observed macroscopically. One target identified in laser phototherapy is a highly specialized enzyme, cytocrome C oxidase, which plays a crucial role in cellular bioenergy [14] .
The results of the present work have shown an improvement in the clinical parameters analyzed (FMPS, FMBS, PPD, and CAL) both at 4 and at 8 weeks after treatment in all groups studied. However, there were no statistically significant intergroup differences. The efficacy of lowlevel laser therapy in periodontal disease is still controversial. Results of the present work are consistent with the ones obtained by different research groups that have used diode laser phototherapy, with even greater power. Kreisler et al. [15] observed that the application of laser radiation from a GaAlAs diode laser (λ0810 nm) at a power of 1 W (cw), did not exert a substantial positive effect on the new insertion of periodontal ligament cells, however, resulted in a significant higher reduction in tooth mobility, pocket depth, and clinical attachment loss, probably due to deepithelization of the periodontal pockets leading to an enhanced connective-tissue attachment. However, no significant group differences were observed in PI, GI, BOP, and sulcus fluid flow rate [16] .
Assaf et al. [17] comparing SRP with ultrasound and SRP with ultrasound and laser diode found no significant differences between the two groups in terms of PI, GI, and PPD, therefore, both treatment groups responded similarly to the therapy from a clinical point of view. However, there are other studies that corroborate the efficacy of phototherapy. For example, Qadri et al. [7] found reductions in PPD, PI, GI, GCF, and MMP-8 that were significantly greater in laser-treated sites. Therefore, the use of a low-power laser as an adjunct to the treatment of periodontal inflammation showed a positive influence on inflammation and healing. Pejčic et al. [18] showed that low-level laser radiation (670 nm) could be used as a successful adjuvant physical treatment method, which, together with traditional periodontal therapy, led to better and longer-lasting therapeutic results (up to 6 months after treatment). In addition, this study clearly showed that the number of laser applications is of paramount importance in order to obtain the best results in irradiated tissue. Namely, after the fifth application, a considerable anti-inflammatory effect was achieved. More recently, the results obtained by De Michelli et al. [19] support the results obtained in this study, showing an improvement in both the control group and the laser group (by using laser diode emitting at 808 nm, applied parallel to the cementum surface with apical-cervical movement for 20s to 1.5 W), in clinical parameters PI and BOP, but no statistically significant intergroup differences reported.
Two important cytokines in relation to the expression of adhesion molecules during most inflammatory processes are TNF-α and IL-1β [20] . Some authors have demonstrated that TNF-α and IL-1β act synergistically in several inflammatory conditions being able to regulate inflammation through constant stimulus for cell migration and the release of inflammatory mediators [21] .
Results of the present work in relation to the levels of proinflamatory mediators in GCF showed a clear increase post-treatment in the SRP group, a maintenance in the case of SRP+PT and a pronounced decrease in the SRP+rPT group. Previous studies carried out at low-level laser energy allow to confirm our results [22, 23] . Recently, Giannopoulou et al. [24] have shown decreased TNF-α levels in GCF at 2 and 8 weeks after diode laser treatment (810 nm; 1 W, 60 s) used as monotherapy. The importance of reducing migration of monocytes and neutrophils to the site of inflammation is that these cells, once attracted to the focus of inflammation secrete TNF-α, and other chemotactic factors, back-feeding the inflammatory process [25] . Thus, the low level laser therapy would contribute to the breakdown of positive feedback loop of inflammation. On the other hand, the results obtained in the SRP group would agree more with the results obtained by Yoshinari et al. [26] who investigated the relationship between clinical changes and IL-1β after conventional periodontal therapy in patients with chronic periodontitis, and showed clear improvement in clinical indices and slight increase in the concentration of IL-1β [26] .
It is well established that immune and inflammatory systems are central to the development of periodontitis. More recently, it has been recognized by the immune system's role in bone metabolism and bone resorption [27] . While a large number of investigations have focused on the treatment of inflammation of the gingival tissues, advances in the understanding of bone metabolism are opening new doors of understanding on the pathologic bone loss in periodontitis. This knowledge, coupled with the development of new drugs or treatment strategies (where the laser could take an important place) that may inhibit the destruction of bone, provides the opportunity not only to treat inflammation of the tissue but also to slow down or stop the destruction of bone observed in periodontitis.
Interaction of three members of the TNF superfamily, RANKL, RANK, and OPG [28] , is important in coordinating osteoclastogenesis and thereby alveolar bone resorption. RANKL is expressed by osteoblasts/stromal cells, fibroblast and activated T cells [29] . It binds directly to RANK on the surface of preosteoclasts and osteoclasts, stimulating both the differentiation of osteoclast progenitors and the activity of mature osteoclasts. On the other hand, OPG is a soluble molecule and a naturally occurring inhibitor of osteoclast differentiation. OPG binds to RANKL with a high affinity and blocks RANKL from interacting with RANK [30] .
A high number of studies to date have analyzed the concentrations and distribution of OPG and RANKL in healthy and in inflamed periodontal tissues For example, the RANKL/OPG ratio is increased in the GCF obtained from patients with chronic periodontitis or aggressive periodontitis compared with that obtained from patients with gingivitis or from healthy patients [31, 32] . These findings identify a promising therapeutic target and have encouraged the development and use of drugs or therapies that modulate the RANKL/RANK/OPG axis, leading to an increase in OPG and a decrease in RANKL, consistent with an equilibrium state between bone formation and bone destruction.
In the present study, the values of the ratio RANKL/OPG were increased during the period evaluated in the SRP group, however, in both the SRP+PT and SRP+rPT groups, these values fell, more marked and immediately in the case of SRP+rPT group. This could be indicative of the lowenergy laser radiation applied mainly in repeated doses in the beginning of the treatment has a beneficial effect of modulating bone locally.
Recently Bostanci et al. [33] conducted a study of 4 months duration, where established that conventional periodontal therapy alone does not alter the tissue capacity to produce these factors. They found that the levels of both RANKL and OPG were increased transiently at 2 months after SRP [32] . This would be consistent with the results obtained in our study with the SRP group, where both factors were increased from the initial state until 8 weeks post-treatment. Furthermore, both results would also be supported by those obtained previously by Santos et al. [34] in a cohort study in patients with diabetes mellitus. This persistence of high levels in the RANKL/OPG ratio after conventional treatment may be indicative in turn of the need for adjunctive treatments that modulate the host response [35] . In any case, a greater number of longitudinal studies in a short and medium term would be required to correlated these factors with clinical and inflammatory indices after the application of laser phototherapy once established the most appropriate irradiation conditions (optimal power and time, frequency and appropriate application modes).
Our results confirmed that the repeated use of Phototherapy reduces the levels in GCF of some proinflammatory mediators as IL-1β and TNF-α, as well as the ratio between RANKL and OPG levels in GCF. Further studies are needed to delve deeper into the mechanisms by which low-level laser radiation exerts these biomodulator effects in periodontal therapy.
